年度完成临床试验报告信息图

INFOGRAPHIC Annual CompletedClinical Trials Report Key insights and results from our annual review of trends inclinical trials completed in 2023, based on Trialtrove data Key Findings After a year of decline in 2022, completed clinical trials were on the upswing again in 2023. According toTrialtrove, 4,295 industry-sponsored clinical trials from Phase I through Phase III/IV either reachedcompleted status or reported primary endpoints during 2023.* This is a 10.7% increase over 2022.*The snapshot of clinical trials completed between Jan. 1, 2023, and Dec. 31, 2023, was taken on Feb. 14, 2024. Trial counts and rankings for completed trials, by year Once again, the oncology therapeutic area (TA) was ranked number one for completed trial activity by a wide margin in 2023.Central nervous system (CNS) returned to third place after being ousted from the top three by infectious diseases during thepandemic years 2021 and 2022. Distribution of 2023 completed trials by therapeutic area and phase Oncology continues to run a relatively high proportion of Phase I/II trials, accounting for 14% of completed trials in this TA in2023. Vaccines and ophthalmology also completed above-average Phase I/II trial activity, each with an 11% share. Top 5 diseases for trials completed in 2023 Even as the COVID-19 pandemic transitioned into the endemic phase, the novel coronavirus remained at the top in terms ofdiseases for which trials were completed in 2023. However, the category did report a 16% decline compared with the previous year. Top 5 sponsors* completing trials in 2023 Pfizer achieved No. 1 status for the second straight year in 2023. Merck & Co. moved up to third place and Roche remained in fourthafter both companies reported their highest completed trials counts in five years. Trialtrove, your one source for trial data Trialtrove is Citeline’s comprehensive clinical trial data solutiondesigned to help you benchmark objectives, endpoints, andenrollment timelines so you can deliver successful trials that meetyour goals. Trialtrove’s experts curate data drawn from over 60,000 sources toanalyze current trends in trial designs and outcomes and give you aclear, comprehensive picture of the competitive landscape. LEARN MORE To learn more about the advantages we can deliver to your company, please visit: Citeline.com or email: info@Citeline.com Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company. Pharma Intelligence UK Limited is a company registered in Englandand Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ